Highlights
NASDAQ: IMMU       Immunomedics Inc
Last Price Today's Change   Day's Range   Trading Volume
17.34   -0.06 (0.34%)  17.07 - 17.64  1,031,800

Overview

 
Avg Volume (4 weeks):1,638,270
4 Weeks Range:14.44 - 17.88
4 Weeks Price Volatility (%):
84.30%
52 Weeks Range:11.55 - 21.23
52 Weeks Price Volatility (%):
59.81%
Average Price Target: 8.00
Price Target Upside/Downside: -9.34

Headlines



No recent Headlines for this stock.


Business Background

Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company’s pipeline includes products targeting solid tumors and hematologic malignancies, among other diseases in clinical and preclinical development. The company is marketing specific diagnostic imaging agents to detect bone infections in Europe, Canada, and Australia. The company has subsidiaries in the Netherlands and Germany to manage sales and clinical trials in Europe.

  Be the first to like this.
 


 

4486  3499  717  224 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.702+0.032 
 FCEL 0.81+0.265 
 AMD 37.52+0.81 
 EEM 42.76-0.33 
 ET 11.16-0.50 
 SPY 309.10+0.10 
 GE 11.29-0.13 
 BAC 32.79-0.30 
 DIS 148.72+10.14 
 XLF 29.61-0.19 
Partners & Brokers